Literature DB >> 27055966

Changes in lipid profile after treatment of women with gestational diabetes mellitus.

Vivian Nunes Kern Pessôa1, Melanie Rodacki2, Carlos Antonio Negrato3, Lenita Zajdenverg2.   

Abstract

BACKGROUND: Insulin resistance, a key factor in the pathophysiology of gestational diabetes mellitus (GDM), is associated with an atherogenic lipid profile. Lipid metabolism is altered during normal pregnancy, but it is still unknown how the treatment of GDM affects lipoprotein concentrations.
OBJECTIVE: To evaluate maternal lipids at GDM diagnosis, after treatment, and in the puerperium and analyze the influence of BMI, insulin requirement, and glycemic control on lipoproteins.
METHODS: In this observational prospective study, total cholesterol (TC), HDL, and triglycerides (TG) were measured, and LDL was calculated at diagnosis (Dx), at 3-6 weeks after GDM treatment initiation (PI, post initiation) and 6-week postpartum (PP). Subgroups analyses were performed according to categories of maternal BMI, insulin requirement, and quality of glucose control.
RESULTS: TC and TG increased from Dx to PI and decreased in PP (TC: 213.6 mg/dL, 223.9 mg/dL, and 195.5 mg/dL; TG: 181.5 mg/dL, 203.5 mg/dL, and 100.5 mg/dL, at Dx, PI, and PP, respectively; P < .0001). HDL declined in the puerperium (Dx = 60 mg/dL, PI = 60.8 mg/dL, PP = 51.8 mg/dL; P < .0001 for Dx-PP and PI-PP, respectively). Insulin-treated patients showed an increase in LDL from Dx to PP, whereas LDL declined in the diet-only group (12 vs -11.1 mg/dL, P = .010). TC and TG increased from Dx to PI in patients with adequate glycemic control and decreased in the uncontrolled subgroup (TC: 15.5 vs -1.2 mg/dL, P = .041; TG: 29.7 vs -12.5 mg/dL, P = .07). No significant differences in lipids variation were observed according to BMI.
CONCLUSIONS: Insulin requirement and glycemic control status directly affected the variation of lipid profile in women with GDM.
Copyright © 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body mass index; Gestational diabetes; Insulin treatment; Lipids; Pregnancy

Mesh:

Substances:

Year:  2015        PMID: 27055966     DOI: 10.1016/j.jacl.2015.12.008

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  2 in total

1.  Polysaccharide IV from Lycium barbarum L. Improves Lipid Profiles of Gestational Diabetes Mellitus of Pregnancy by Upregulating ABCA1 and Downregulating Sterol Regulatory Element-Binding Transcription 1 via miR-33.

Authors:  Shuli Yang; Lihui Si; Limei Fan; Wenwen Jian; Huilin Pei; Ruixin Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-23       Impact factor: 5.555

2.  Gestational Diabetes Mellitus Treatment Schemes Modify Maternal Plasma Cholesterol Levels Dependent to Women´s Weight: Possible Impact on Feto-Placental Vascular Function.

Authors:  Susana Contreras-Duarte; Lorena Carvajal; María Jesús Garchitorena; Mario Subiabre; Bárbara Fuenzalida; Claudette Cantin; Marcelo Farías; Andrea Leiva
Journal:  Nutrients       Date:  2020-02-17       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.